The 2014 Shenzhen International Biological/Life & Health Industry Exhibition was successfully held from September 10th to September 12th. ISKCON participated in the exhibition and won the gold and silver awards for innovation achievements.

The exhibition concentratedly displayed the products of nearly 150 companies, released nearly 80 innovative projects, held 41 professional forums, nearly 20 promotion meetings, matchmaking meetings, and press conferences. 200 companies conducted on-site negotiations and dockings, and received professional visitors. 12,000 people. In order to commend the annual outstanding innovative enterprises in the biological/life health industry, lead the development of the biological/life health industry, and promote the technical exchange of high-end resources in the entire industry chain of the biological field, the selection committee composed of the host unit, experts, scholars, and the media is based on the basic Comprehensive evaluation of the situation, enterprise innovation system, innovation investment, innovation awareness, award certification status, brand image, etc., selected 20 "2014 Bio/Life Health Industry Innovation Achievement Gold Award" and "2014 Bio/Life Health Industry Innovation Achievement Silver Award" Award" 50 people.

Ishikoning has been committed to the technical development, technical certification, technical review and technical promotion of ACTL targeted anti-tumor cell immune technology (ACTL). It is a high-tech biological enterprise integrating R&D, production, sales and service. Under the planning and strategic guidance of the Ministry of Science and Technology and the National Development and Reform Commission, ISKCON will more actively carry out independent research and development and transformation of results to promote the development of the domestic biomedical industry.